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Abstract
The present study investigated the prevalence of HIV-1 multiple infections in a population composed by 47 patients under
HAART failure and enrolled at the National DST/AIDS, Program, Ministry of Health, Brazil.Detection of multiple infections was
done using a previously published RFLP assay for the HIV-1 protease gene, which is able of distinguishing between
infections caused by a single or multiple HIV-1 subtypes. Samples with multiple infections were cloned, and sequence data
submitted to phylogenetic analysis. We were able to identify 17 HIV-1 multiple infections out of 47 samples. Multiple
infections were mostly composed by a mixture of recombinant viruses (94%), with only one case in which protease gene
pure subtypes B and F were recovered. This is the first study that reports the prevalence of multiple infections and
intersubtype recombinants in a population undergoing HAART in Brazil. Based on the data there was a steep increase of
multiple infections after the introduction of the combined antiretroviral therapy in Brazil. Cases of multiple infections may
be associated with HIV-1 genetic diversity through recombination allowing for the generation of viruses showing a
combination of resistance mutations.
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Introduction
According to the UNAIDS there are more than 34 million
people living with HIV-1. The global distribution of HIV-1
infections is not uniform. The Sub-Saharan Africa accounts for
23.5 million infections being the most prevalent region [1]. HIV-1
subtype distribution is not balanced. There are regions affected by
mostly one predominant viral variant while others demonstrate the
simultaneous circulation of more than one subtype [2]. Subtype B
dominates the HIV-1 epidemic in Western Europe, and in the
USA. On the other hand, almost all subtypes have been described
in Central Africa [3,4]. The co-circulation of more than one HIV-
1 genetic form in the same population may lead to multiple viral
infections, which may offer an opportunity for viral recombination
[3]. Recombination is an important feature of the HIV-1
pandemics. There are 58 distinct HIV-1 circulating recombinant
forms (CRFs) posted on the Los Alamos HIV-1 Database as of
January 2013 [5]. Although some of these recombinant forms are
composed by a mixture of two different subtypes others have more
than two genetic origins and are referred to as complex
recombinants. Is it also noteworthy that a few CRFs may
represent a second generation of recombinant forms since they
bear in their structures segments belonging to other previously
described CRFs. CRFs represent 20% of all HIV-1 infections
worldwide [2,6]. CRF01_AE and CRF02_AG account for
approximately 3.6 million infections. Moreover, in places where
more than one HIV-1 subtype circulates, 30% of the infected
individuals may carry HIV-1 unique recombinant forms [2,7].
The high prevalence of recombinants suggests that multiple
infections may not be rare [8–13]. Multiple infections result from
either coinfections (acquisition of two distinct viruses at the same
time) or superinfections (sequential acquisition of distinct viruses).
Superinfections may result in the acquisition of drug-resistant
isolates [14] and accelerated disease progression [15]. A study
conducted in 2010 with elite controllers found that superinfections
were associated with disease progression [16]. Gottlieb and
colleagues [17] studying four cases of HIV-1 coinfections and
one superinfection noted that infections caused by mixed virus
populations evolved at an accelerated pace to clinical AIDS or to
TCD4 counts of less than 200/mm3 when compared to single
infections. However, Fung and colleagues [18] using a mathe-
matical model inferred that superinfections do not trigger or
accelerate progression to disease.Some studies noted that pro-
longed highly active antiretroviral therapy (HAART) may
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Figure 1. Protease gene phylogenetic classification of HIV-1 multiple infections. Multiple infections are represented on the tree by
different branches showing the same icon at their tips. Samples 2675, 2831, 2826, 3013, 3038, 3430 and 3602 correspond to simple infections. The NJ
tree was built using TVM + C as the nucleotide substitution model.
doi:10.1371/journal.pone.0084066.g001
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influence the immune response [19,20]. It is believed that long
term viral suppression may affect antibody titers and the lack of
neutralizing antibodies may favor superinfections [20]. However,
Piantadosi and colleagues [21] reported several cases of HIV-1
superinfections in which patients were not under HAART. The
study of HIV-1 multiple infections is essential in areas where
multiple HIV-1subtypes co-circulate. As mentioned above, mul-
tiple infections may increase the genetic complexity of virus
populations [22]. Furthermore, superinfections may interfere with
the HAART success and affect disease progression by the
sequential acquisition of viruses with different resistance associated
mutations [14,23].
HIV-1 multiple infections caused by viruses from the same
or different subtypes have been previously reported
[10,13,17,20,21,24–42,43–49]. This type of infection has been
mostly identified in populations at high risk of becoming infected
by HIV-1. These populations correspond to groups of inject drug
users (IDUs), men who have sex with men (MSM), and sex
workers. HIV-1 multiple infections ranged from 1.4% to 19%
among African sex workers [17,21,33,37–39,50]. It also accounted
for 25% of all HIV-1 cases in a population of MSM in the USA
[30]. Of note, in 2007 a study addressing a criminal case involving
14 newly infected MSM in Holland demonstrated the presence of
multiple infections in half of the subject individuals [27]. HIV-1
multiple infections varied from 1.5% to 6% among IDUs in
Thailand [35,42,48]. Templeton and co-workers [28] found that
multiple infections corresponded to 40% of the total number of
HIV-1 infections in a population of IDUs enrolled in a 6 year
study (1994–2000). In populations without a defined risk of
exposure, multiple infections were detected from 8% to 15% from
the total HIV-1 studied cases [25,26,10].
In South America, the majority of studies have been done
addressing populations in Brazil and Argentina. A study from
2000 detected 1.7% of HIV-1 multiple infections in Buenos Aires
[44]. In 2007, while addressing a population of IDUs in Argentina,
Pando et al. [32] found that multiple infections corresponded to
6% of all studied cases. In a recent investigation [24] conducted on
a group of 23 Argentinean patients at a high HIV-1 exposure risk,
multiple infections were detected in 5 of them. Four of these
infections were composed by subtype B and BF recombinant
viruses. The fifth multiple infection had only BF recombinants.
In Brazil several HIV-1 subtypes co-circulate. The first subtype
introduced in Brazil was most likely subtype B followed by
subtypes F and C. In regions such as the Southeast, the presence of
more than one circulating subtype maybe is related to the
detection of recombinant forms. The majority of these recombi-
nants correspond to unique recombinants most likely arising from
different multiple HIV-1 infection events [51–53]. Furthermore,
six CRFs have been described in Brazil [54–57]. Since the late
Table 1. Breakpoints and Recombination Individuals.
Samples Subtype RecombinationInterval Breakpoint (BP)
2628 B/F 50–78 64
2628 B/F 58–82 70
2628 B/F 58–82 70
2628 B/F 65–82 73
2664 B/F 182–190 186
2664 B/F 184–188 186
2664 B/F 184–188 186
2664 B/F 183–189 186
2696 B/C/B 141–145/155–159 143/157
2699 F/B 127–131 129
2699 B/F 188–220 204
2699 B/F 186–220 203
2699 B/F 185–189 187
2699 B/F 186–220 203
2699 B/F 186–202 194
2704 B/F 76–81 78
2704 B/F 60–79 69
2704 B/F 60–79 69
2704 B/F 60–79 69
2704 B/F 185–189 187
2704 B/F 185–189 187
2704 B/F 171–207 189
2704 B/F 174–204 189
2704 B/F 188–220 204
2704 B/F 170–208 189
2704 B/F 188–220 204
2704 B/F 185–193 189
2713 B/F 139–151 145
2713 B/F 137–153 145
2713 B/F 188–220 204
2757 B/F 186–190 188
2757 B/F 186–190 188
2757 B/F 143–147 145
2757 B/F 186–200 193
2757 B/F 186–190 188
2757 F/B 170–174 172
2816 B/F 186–190 188
2816 B/F 186–190 188
2837 F/B 141–159 150
3018 B/F 185–189 187
3018 B/F 185–189 187
3018 B/F 185–189 187
3018 B/F 185–189 192
3018 B/F 185–189 187
3032 F/B 219–227 223
3032 F/B 218–228 223
3041 F/B 135–157 146
3041 B/F 185–189 187
3400 B/F/B 84–100/138–142 92/140
Table 1. Cont.
Samples Subtype RecombinationInterval Breakpoint (BP)
3400 B/F/B 84–100/138–142 92/140
3400 B/F/B 83–101/133–147 92/140
3400 B/F/B 84–100/138–142 92/140
3422 F/B 219–223 221
3422 F/B 218–224 221
4145 B/F/B 88–93/138–166 93/152
doi:10.1371/journal.pone.0084066.t001
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nineties, the Brazilian Ministry of Health has been funding the
distribution of antiretroviral treatment.
The first studies on dual infections in Brazil were done prior to
the introduction of HAART. In the 1990s, Janini and coworkers
[47] and Ramos et al [45] found that multiple infections
corresponded respectively to 3 and 3.8% when studying popula-
tion groups in Brazil. The combination between the co-circulation
of multiple subtypes and a broadly accessible HAART might have
created the necessary conditions leading to an increase in multiple
infections. This study aimed to assess the prevalence of multiple
infections in patients experimenting virological failure while under
HAART and living in the Southeast of Brazil. We used as trial a
previously published restriction length polymorphism assay
(RFLP) based on the HIV-1 protease gene digestion patterns
[47]. RFLP data was confirmed by cloning, sequencing and
phylogenetic trees. Multiple infections corresponded to 36% of all
HIV-1 infections in the studied subjects. All but one multiple
infections showed the presence of recombinant viruses. This data
indicates that multiple infections may be taken into account as a
driving force increasing the genetic complexity of the HIV-1
epidemic in the Southeastern region of Brazil.
Materials and Methods
The study was Institutional Review Board approved at the
Federal University of Sao Paulo, Brazil, and written informed
consent has been obtained (process number in research ethics
committee 0075/09).
Studied population
Peripheral blood samples were obtained from 47 HIV-1
infected individuals living in the cities of Sao Paulo and Santos
and enrolled at the governmental program of Sexually Transmit-
ted Diseases/AIDS (DST/AIDS), Ministry of Health – Brazil.
Figure 2. Bootscan analysis of HIV-1 multiple infections based on the protease gene.We used the Neighbor-Joining method with K2P and
1000 bootstrap replicates. This analysis was performed using the software Simplot v3.5.1, with a window of 75 bp and 5 bp increments.
doi:10.1371/journal.pone.0084066.g002
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Samples were collected during 2006 and 2008. Patients were
under highly active antiretroviral treatment according to the
Brazilian Government Guidelines for Antiretroviral Therapy.
Polymerase chain reaction (PCR)
Viral DNA was extracted and used as target to amplify a 297-bp
fragment corresponding to the HIV-1 protease gene. Nested PCR
conditions and the set of primers used were described by Janini
et al. [47].
Restriction fragment length polymorphism analysis
(RFLP)
Restriction enzyme reactions consisted of 8 uL of the PCR
product corresponding to the amplified viral protease gene, 3U of
AluI restriction enzyme (Invitrogen), and 1 mL of enzyme buffer
supplied by the manufacturer. Digestions were performed
according to Janini et al. [47]. After incubation at 37uC for
2 hours, digested products were analyzed by agarose gel (1%)
electrophoresis and stained with SYBERH Safe DNA Stain
10.000X (Invitrogen). Positive controls representing different
HIV-1 subtypes were included to provide known restriction
fragment patterns.
Cloning and Sequencing
PCR-amplified proteasesequences were cloned into thepDrive
cloning vector using the QIagen PCR Cloning Kit (QIAGEN
Inc.). A minimum of 12 and a maximum of 70 clones were
obtained from each sample in order to isolate sequences with
distinct phylogenetic origins. Clones were screened by the protease
gene RFLP assay. Sequence reactions were performed using the
Big-Dye Terminator v3.1 Cycle Sequencing (Applied Biosystems),
according to the manufacturer’s instructions and analyzed using
the ABI 3130 xl Genetic Analyzer Program (Applied Biosystems).
Analysis of Results
Sequences were assembled using the Sequencher software
version 4.1.4 (Gene Codes Corporation). Resulting sequences
were manually edited with BioEdit version 7.0.0 (Ibis Biosciences,
USA) [58]. Protease sequences were aligned using the program
Muscle V3.8.31 [59].
Phylogenetic Inference
Phylogenetic inferencewas performed using Paup 4.0 Beta [60] in
association with Modeltest version 3.7 [61]. Phylogenetic analysis
was performed using the Neighbor Joining (NJ) method and the
TVM + C was the most appropriate nucleotide substitution model.
Constructed trees were checked by 1000 bootstrap replicates. Trees
were edited using the software Figtree [62].
Detection of Recombination
Inter-subtype recombinants and breakpoints were investigated
using Bootscan as implemented in the Simplot package v3.5.1
[63]. Bootscananalysis was based on the Neighbor-Joining
algorithm with the K2P model and was evaluated by 1000
bootstrap replicates. The analysis was performed with an 75nt
window and 5 nt increments.
Results
We addressed samples from HAART experienced patients
under virological failure and enrolled at the governmental
program of Sexually Transmitted Diseases/AIDS (DST/AIDS),
Brazil. Using a combination of protease gene RFLP assay followed
by cloning and sequencing analysis we were able to identify 17
HIV-1 multiple infections out of 47 tested samples. These multiple
infections were composed by mainly subtype B and F protease
sequences and BF recombinants with one case of a BCB
recombinant. In our study all but 2 subtype F protease gene
sequences were in fact BF recombinants. Samples showing
multiple protease gene RFLP digestion patterns were cloned and
sequenced. Sequences from all 17 multiple infections and 7 from
simple infections were used along protease gene subtype specific
reference strains obtained from GenBank to build a NJ
phylogenetic tree. (GenBank accession numbers: subtype B
references from Brazil AY173956, EF637057, from California
DQ322225 and from Argentina DQ383748; subtype C from
Brazil GU982733; subtype F from Brazil AY900894, FJ591905
and sub-subtype F1 from Brazil DQ899684 and FJ405153). This
tree is shown in Figure 1. Sequences generated in this study were
granted the GenBank accession numbers KF767573– KF767672.
Pure subtype B protease gene sequences in dark blue formed a
major and well defined cluster seen at the bottom of the tree. Pure
subtype F sequences (in brown) interspersed by FB (orange), BF
(red) and BFB (green) recombinants were grouped at the top of the
tree forming an isolated cluster emerging from a single ancestral
node. The protease gene sequence obtained from the sample 2743,
which was a recombinant between an unclassified segment and
subtype F, also grouped within this cluster.
Two other groups of sequences composed by exclusively
recombinant protease gene sequences can be seen at the middle
of the tree. First, an isolated group containing only FB and BFB
recombinants and a second cluster formed by BF recombinants
emerging from a branch contained within the pure subtype B
cluster. The emergence of the above mentioned BF cluster as well
as other minor clusters as the BFB group of sequences and the
BCB recombinant sequence (light blue) from within the pure
subtype B group implies a phylogenetic relatedness of these
recombinants with pure subtype B protease gene sequences used
here. The overall placement of recombinants in the tree was
strongly influenced by their subtype content. As an example, BFB
recombinants from samples 3400 and 4145 differed in their
subtype F content by only 14 nucleotides what was sufficient to
grant their separation in two distant clusters. In the tree multiple
infections are represented by distinct branches showing geometric
symbols at their tips. Each multiple infection is represented by a
unique symbol. By following the symbols it is clear that sequences
from multiple infected patients grouped within different clusters,
enabling us to infer that each patient carried an infection
composed by phylogenetically distinct virus (Figure 1). Single
infections are represented in the tree by sample numbers. Samples
3032, 3422, 2704, 2696, 2629, 2743, 2628, 3018, 3400, 2713,
2757, 3041, 4145, 2699, 2664, 2837 and 2816 corresponded to the
17 multiple infections detected in our study while samples 2675,
2831, 2826, 3013, 3038, 3430 and 3602 were HIV-1 single
infections.
The Bootscan analysis confirmed the genetic composition of the
17 HIV-1 multiple infections by demonstrating that the majority
of multiple infections were composed by a combination of pure
subtype B protease sequences and recombinants. According to the
Bootscan analysis multiple HIV-1 infections corresponded to 3
triple infections composed each one by the simultaneous presence
of viruses containing pure B subtype protease gene sequences and
BF and FB recombinants; 4 double infections composed by pure
subtype B viruses and BF recombinants; 2 double infections
composed by pure subtype B and FB recombinants; 2 double
infections composed by BF and FB recombinants; 2 double
infections composed by pure subtype B and BFB recombinants; 1
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double infection composed by pure subtype B and a BCB
recombinant; 1 double infection composed by pure subtype F and
a FB recombinant; and one double infection composed by
protease genes from pure B and F subtypes.
Among recombinants, BF mosaics generally predominated over
the other recombinants. The second most prevalent mosaics were
FB recombinants followed by BFB structures, 1 BC recombinant
and 1 unclassified/F strain. Breakpoints were defined as the
midpoint of an interval flanked by two distinct phylogenies.
Breakpoints and recombination intervals can be seen in table 1.
Although the criteria used to assign a subtype to any sequence was
based on a 70% bootstrap value threshold, in the sample 3400 the
subtype F sequence stretch had a bootstrap value close to 50%
(Figure 2). However BFB recombinants placed distantly from pure
subtype B protease gene sequences from this patient in the tree
(Figure 1) indicating this was a real HIV-1 multiple infection case.
Figure 2 shows Bootscan illustrations from 4 representatives
HIV-1 multiple infections. In the top panel patient 2699 harbors a
triple infection composed by virus belonging to pure subtype B
and FB and BF recombinants. In the top middle panel, patient
3400 shows a HIV-1 double infection by pure subtype B virus and
BFB recombinants. The lower middle panel shows a case of a
double infection by pure subtype B virus and a BCB recombinant
(patient 2696) and in the lower panel one double infection by pure
subtype F and FB recombinants (patient 3032).
In Figure 3 schematic mosaic structures of recombinants and
pure subtypes found in each patient are represented. The number
of times that a particular subtype or recombinant form was found
in a patient is shown inside the parenthesis to the left of each
structure. In the table within the figure, breakpoint positions in
base pairs are followed by the number of times they appear in each
multiple infection (inside the parenthesis). It is clear that according
Figure 3. Schematic mosaic structures and pure subtypes found in multiple infections. The number of times that a particular subtype or
recombinant was found in a patient is shown inside the parenthesis to the left of each structure. Break points were mapped according to Bootscan
and their positions in base pairs are followed by the number they appeared on mosaic structures (inside the parenthesis).
doi:10.1371/journal.pone.0084066.g003
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to the mosaic schemes majority of recombinants were patient
specific.
Breakpoints were distributed all over the protease gene
sequence indicating the absence of clear recombination hotspots
among the mosaic sequences. However, it is interesting to note
that the same recombination breakpoint appears more than once
in a patient, such as in patient 2628 and also between different
patients as in patients 2699, 2704 e 3018. Breakpoint distribution
and times they appear along the protease gene are represented in
Figure 4.
Discussion
This study addressed the presence of HIV-1 multiple infections
in samples obtained from patients during HAART failure. Using a
previously published protease gene RFLP assay followed by
cloning and sequencing we were able to identify 17 HIV-1
multiple infections out of 47 samples. Multiple infections
corresponded to 36% of all HIV-1 infections among the studied
subjects. The percentage of HIV-1 multiple infections found here
is between 9 to 12 times greater than the percentages encountered
in studies by Janini et al [47] and Ramos et al. [45]. These studies
were conducted in Brazil in the early nineties before the
introduction of HAART. Although some publications indicated
that HIV-1 multiple infections could be detected in up to 40 to
50% of studied cases, most of those investigations addressed
particular situations or were associated with populations exposed
to risky behavior, with multiple exposures through the sexual route
or by intravenous drug use [27,28,35,40,42,48].
In contrast, we found an elevated frequency of multiple
infections in a population that was not uniformly composed by
individuals at an increased risk of HIV-1 exposure. The increased
number of multiple infections among patients living in the cities of
Sa˜o Paulo and Santos may be reflecting aspects of the epidemic in
the Southeast region of Brazil. Among these are the co-circulation
of distinct subtypes and recombinants and the presence of an
efficient and tight transmission chain. The Southeast region of
Brazil, where the city of Sa˜o Paulo is located, has the majority of
the HIV-1 cases in the country [53,66]. Because some studies have
addressed HIV-1 superinfections in treatment experienced
Figure 4. Protease gene break point positions in nucleotides and their frequency. X axis indicates the number each breakpoint was
detected in our study. Break points detected in single patients are represented by Y axis bars in blue whereas; break points detected in multiple
patients appear in multicolored bars. The numbers inside parenthesis are the number of different patients in which this particular break point was
detected.
doi:10.1371/journal.pone.0084066.g004
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patients, [14,19] it is tempting to speculate that the observed
increase of HIV-1 multiple infections also holds a relationship with
the introduction of HAART in Brazil. Since the late nineties the
Brazilian Government has been applying funds making HAART
broadly accessible to Brazilian HIV-1 infected individuals. Long
term suppression of virus replication might favor superinfection by
drug resistant variants resulting in increased numbers of multiple
infections among patients experiencing treatment failure.
Although we could successfully identify many cases of multiple
infections, the study of this type of infections can be difficult.
Approaching clinical samples by direct sequencing without cloning
may result in failure to detect minor viral populations which might
become predominant at a later time [70]. The application of a trial
methodology prior to sequencing may facilitate sorting HIV-1
multiple infections from single infections. We believe that by using
a previous described RFLP assay based on the HIV-1 protease
gene digestion patterns our power to detect multiple infections was
increased [47]. The simultaneous presence of more than one
protease gene digestion patterns was used as indicative of multiple
infections. Samples with multiple digestion patterns were subse-
quently cloned and sequenced. Moreover, the protease gene is a
fairly conserved gene what facilitates PCR detection and
according to several previous publications [67–69], proved to be
a gene with sufficient phylogenetic signal to classify samples.
The elevated frequency of HIV-1 multiple infections described
here suggests that the genetic complexity of the HIV-1 epidemic in
at least the Southeastern region of Brazil is indeed increasing.
One of the outcomes of HIV-1 multiple infections is the
recombination between distinct viral populations [2]. Recombi-
nation can lead to evolutionary leaps and facilitate the emergence
of particles with different phenotypic characteristics and may
accelerate the process of viral adaptation to a host or host
population [64,65]. Lately, a steady increase in the numbers of
reported HIV-1 recombinant strains have been observed in the
Brazilian epidemic [54–57]. In this scenario, it is acceptable to
think that the increasing numbers of multiple infections has been
fuelling the generation of recombinant strains in Brazil.
From the 17 multiple infections detected in our study, 16
involved the presence of recombinants. According to the protease
gene, only one multiple infection was composed by pure subtype
viruses. In this case one virus population belonged to subtype B
and the other to subtype F. Of the remaining 16 multiple
infections, 14 were composed by viruses with their protease genes
showing a mixture of subtypes B and F along with viruses that had
the protease gene classified as either pure subtype B or pure
subtype F. Of the two remaining multiple infections, one was
composed by a combination of subtype B and BC recombinant
viruses, and the other by a mixture of pure subtype B and an
undefined/F recombinant. Once more, our findings are in
agreement with the distribution of HIV-1 subtypes in the Brazilian
epidemic. The Southeast is a region where subtypes B and F co-
circulate, in this manner recombinants between these two subtypes
can be expected [53,66].
After the analysis of recombinant sequences obtained from
multiple infections, it became clear that they corresponded to a full
spectrum of BF recombinants. Recombinants ranged from mostly
subtype B to mostly subtype F with many of them showing
different percentages of subtypes B and F to their structures. This
spectrum can be easily visualized in Figure 3. The tree topology
demonstrates distinct clusters of recombinants, with groups formed
by recombinants with more subtype B than F (red cluster) and with
more subtype F than B (orange sequences). This observation
suggests that subtypes B and F are getting mixed with each other
through frequent multiple infections followed by recombination.
As mentioned before, in one sequence the 59 portion of the
protease gene remained unclassified. It is possible that the intense
mixing of subtypes B and F with the presence of multiple
breakpoints may have rendered this fragment unclassifiable. The
intense mixture of subtypes B and F isn’t new to the South
American epidemic [2]. Several distinct CRFs with subtypes B and
F have been described. The South American BF CRFs are
composed by different portions of subtypes B and F [2,5]. Our
data support the idea that frequent multiple infections followed by
recombination are helping subtypes B and F to merge in South
America. As an example, we were able detected three triple
infections being all composed by subtype B virus, BF and FB
recombinants.
The Bootscan analysis demonstrated recombinants correspond-
ed to different BF mosaics. Many of these mosaics showed patient
specific patterns, suggesting the presence of intrapatient recombi-
nation. On the other hand, detection of some BF forms showing a
very similar mosaic structure in more than one patient indicated
that some recombinants may represent a still not well defined CRF
expanding in the study population. This CRF could be a
component of many multiple infections. However, we found no
correlation between our recombinant patterns and the already
described CRFs in the HIV-1 epidemic in Brazil (data not shown).
Since the addressed genomic region in our study corresponded to
the protease gene we were unable to make any assumptions
regarding the genomic structure of these recombinants or of
putative CRFs.
Finally, in the present study we describe a high percentage of
HIV-1multiple infections in samples from individuals undergoing
HAART and experiencing treatment failure. Long term viral
suppression might offer an opportunity to superinfection caused by
drug resistant virus [14,71–73]. However, to access the distribu-
tion of multiple infections in Brazil and its correlations with
HAART other population groups need to be approached. We
were able to detect many distinct recombinants as part of multiple
infections. Further studies using longer subgenomic segments or
full length HIV-1 genomes might reveal an even greater number
of HIV-1 recombinants in the Southeastern region of Brazil.
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